Colorectal cancer (CRC) therapy mainly relies on the use of conventional chemotherapeutic drugs combined, in a subset of patients, with epidermal growth factor receptor [EGFR]-targeting agents. Although CRC is considered a prototype of a cancer stem cell (CSC)-driven tumor, the effects of both conventional and targeted therapies on the CSC compartment are largely unknown. We have optimized a protocol for colorectal CSC isolation that allowed us to obtain CSC-enriched cultures from primary tumor specimens, with high efficiency. CSC isolation was followed by in vitro and in vivo validation, genetic characterization, and drug sensitivity analysis, thus generating panels of CSC lines with defined patterns of genetic mutations and therapy sensitivity. Colorectal CSC lines were polyclonal and maintained intratumor heterogeneity in terms of somatically acquired mutations and differentiation state. Such CSC-enriched cultures were used to investigate the effects of both conventional and targeted therapies on the CSC compartment in vivo and to generate a proteomic picture of signaling pathways implicated in sensitivity/resistance to anti-EGFR agents.Wepropose CSC lines as a sound preclinical framework to test the effects of therapies in vitro and in vivo and to identify novel determinants of therapy resistance.

De Angelis, M. L., Zeuner, A., Policicchio, E., Russo, G., Bruselles, A., Signore, M., Vitale, S., De Luca, G., Pilozzi, E., Boe, A., Stassi, G., Ricci-Vitiani, L., Amoreo, C. A., Pagliuca, A., Francescangeli, F., Tartaglia, M., De Maria Marchiano, R., Baiocchi, M., Cancer stem cell-based models of colorectal cancer reveal molecular determinants of therapy resistance, <<STEM CELLS TRANSLATIONAL MEDICINE>>, 2016; 5 (4): 511-523. [doi:10.5966/sctm.2015-0214] [http://hdl.handle.net/10807/112022]

Cancer stem cell-based models of colorectal cancer reveal molecular determinants of therapy resistance

De Angelis, Maria Laura;Russo, Giorgio;Vitale, Sara;Pagliuca, Alfredo;Francescangeli, Federica;Tartaglia, Marco;De Maria Marchiano, Ruggero;
2016

Abstract

Colorectal cancer (CRC) therapy mainly relies on the use of conventional chemotherapeutic drugs combined, in a subset of patients, with epidermal growth factor receptor [EGFR]-targeting agents. Although CRC is considered a prototype of a cancer stem cell (CSC)-driven tumor, the effects of both conventional and targeted therapies on the CSC compartment are largely unknown. We have optimized a protocol for colorectal CSC isolation that allowed us to obtain CSC-enriched cultures from primary tumor specimens, with high efficiency. CSC isolation was followed by in vitro and in vivo validation, genetic characterization, and drug sensitivity analysis, thus generating panels of CSC lines with defined patterns of genetic mutations and therapy sensitivity. Colorectal CSC lines were polyclonal and maintained intratumor heterogeneity in terms of somatically acquired mutations and differentiation state. Such CSC-enriched cultures were used to investigate the effects of both conventional and targeted therapies on the CSC compartment in vivo and to generate a proteomic picture of signaling pathways implicated in sensitivity/resistance to anti-EGFR agents.Wepropose CSC lines as a sound preclinical framework to test the effects of therapies in vitro and in vivo and to identify novel determinants of therapy resistance.
Inglese
De Angelis, M. L., Zeuner, A., Policicchio, E., Russo, G., Bruselles, A., Signore, M., Vitale, S., De Luca, G., Pilozzi, E., Boe, A., Stassi, G., Ricci-Vitiani, L., Amoreo, C. A., Pagliuca, A., Francescangeli, F., Tartaglia, M., De Maria Marchiano, R., Baiocchi, M., Cancer stem cell-based models of colorectal cancer reveal molecular determinants of therapy resistance, <<STEM CELLS TRANSLATIONAL MEDICINE>>, 2016; 5 (4): 511-523. [doi:10.5966/sctm.2015-0214] [http://hdl.handle.net/10807/112022]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10807/112022
Citazioni
  • ???jsp.display-item.citation.pmc??? 24
  • Scopus 40
  • ???jsp.display-item.citation.isi??? 39
social impact